Actual causes of Parkinsons disease (PD) are still unknown. In any case, a better comprehension of genetic and ecological influences to the PD and their interaction will assist physicians and patients to evaluate individual hazard for the PD, and definitely, there will be a possibility to find a way to reduce the progression of the PD. We introduced quantitative frameworks to reveal the complex relationship of various biasing genetic factors for the PD. In this study, we analyzed gene expression microarray data from the PD, ageing (AG), severe alcohol consumption (AC), type II diabetes (T2D), high body fat (HBF), hypercholesterolemia (HC), high dietary fat (HDF), red meat dietary (RMD), sedentary lifestyle (SL), smoking (SM), and control datasets. We have developed genetic associations of various factors with the PD based on the neighborhood-based benchmarking and multilayer network topology.
I. INTRODUCTION
Parkinson's disease (PD) is an interminable and gradual degenerative disorder mainly invading the motor system of the central nervous system [1] . It is one of the most common neurodegenerative problems after Alzheimers illness all over the world [2] . The PD is characterized by progressive damage of dopaminergic neurons in the substantia nigra pars compacta and neuronal inclusions composed of -synuclein. These neuronal inclusions which are situated in neuronal perikarya are referred to as Lewy bodies [3] . Subtle early symptoms of the PD appear slowly over time that comprises shaking, rigidity, slowness of movement and walking complications. Patients suffer from complications to walk, talk or even complete other simple daily activities. Sensory, sleep and emotional problems may also evident in the PD. Most often the PD leads to dementia [4] . Approximately 60,000 Americans are diagnosed with the PD each year in the United States which is estimated to reach 1 million by 2020. More than 10 million people are living with the PD worldwide [5] . Although ample discoveries are continuing in this field, the exact causes or risk factors are still poorly understood [2] . Men are more likely to have the PD than women and the domination increases with age. 1% of the total population above 60 years have the PD, whereas only 4% of total cases are estimated at the age of below 50 years [6] . The risk for the PD in humans can significantly be reduced by midlife exercise [7] . Smoking, consumption of alcohol, vitamin D exposure and urate levels are the dominant environmental components that may stimulate the risk of the PD [8] . Moderate doses of caffeine have a protective risk of the PD [9] . Again, the risk of the PD is increased with high total cholesterol at baseline [10] . A diet containing lower saturated fats might lessen the threat of the PD [11] . Type II diabetes weakens the resistance against the PD [12] . The exclusion of dietary red meat boosts the recovery process for several motor functions in the PD affected people [13] . Molecular associations, such as differential gene expressions, protein-protein interactions (PPIs), gene ontologies and metabolic pathways can be genetic associations of various risk factors as the influential causes of the diseases [14] , [15] . Any risk factor can be attributed to the disease if they share the common set of differentially expressed genes [16] , [17] . But from a proteomics and signaling pathways point of view, they are associated through biological modules such as PPIs, gene ontologies or molecular pathways [18] , [19] .
Network-based approaches for genetic studies of various diseases have become very popular in recent years [20] , [21] , [22] , [23] . Several genetic studies have been conducted to demonstrate the various risk factors of the PD, but none of them used network-based approaches [24] , [25] , [26] , [27] .
In this article, a network based analysis to identify the genetic influence caused by associated factors and disorders for the PD progression is demonstrated utilizing the gene expression profiling, PPI sub-network, gene ontologies and molecular pathways. An extensive study regarding phylogenetic and pathway analysis is also conducted to reveal the genetic associations of the PD.
II. MATERIALS AND METHODS

A. Data
We have analyzed gene expression microarray datasets to identify the association of different factors with the PD at the molecular level. All the datasets used in this study were collected from the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (https://www.ncbi.nlm.nih.gov/geo/). Ten different datasets with accession numbers: GSE7621, GSE23343, GSE25941, GSE1786, GSE68231, GSE13985, GSE6573, GSE25220, GSE52553 and GSE4806 are analyzed for this study [28] , [29] , [30] , [31] , [32] , [33] , [34] , [35] , [36] . The PD dataset (GSE7621) is obtained by RNA extraction and hybridization on Affymetrix microarrays of Substantia nigra tissue from postmortem brain of healthy and the PD patients. The type II diabetes (T2D) dataset (GSE23343) contains gene expression data obtained through extensive analysis after conducting liver biopsies in humans. The hypercholesterolemia (HC) dataset (GSE13985) is obtained from RNA sample of white blood cells of 10 different samples using Affymetrix microarrays. The age (AG) dataset (GSE25941) is a global microarray data from skeletal muscle transcriptome of 28 different subjects. The sedentary lifestyle (SL) dataset (GSE1786) was obtained by expression profiling array from the vastus lateralis muscle using needle biopsies. The high-fat diet (HFD) dataset (GSE68231) is the expression data from human skeletal muscle identifying accumulation of intramyocellular lipid (IMCL). The high body fat (HBF) dataset (GSE6573) is an Affymetrix human gene expression array data from the abdominal fat tissue. The red meat dietary (RMD) intervention dataset (GSE25220) is an Agilent-014850 whole human genome microarray data from human colon biopsies before and after participating in a high red-meat dietary intervention. The alcohol consumption (AC) dataset (GSE52553) is an Affymetrix human gene expression array data of Lymphoblastoid cells from 21 alcoholics and 21 control subjects. The smoking (SM) dataset (GSE4806) is a gene expression profile of Tlymphocytes from smokers and non-smokers.
B. Method
Nowadays experimental approach based on oligonucleotide microarray data to assess gene expression levels has been found to be an effective and responsive technique to demonstrate the molecular factors of human disorders. In this study, we used this methodology along with global transcriptome analysis to investigate the gene expression profiles of the AD with 8 risk factors and type II diabetes. Since various errors are usually introduced in preparing and analyzing microarray data of different platforms and experimental system, the gene expression data in each sample (disease state or control) need to be normalized. The Z-score transform is one of the most widely used normalization methods of gene expression matrix.
Let x ij be the expression value of i-th gene in sample j, then normalization using Z-score transform is obtained as follows:
where σ i and all samples respectively. This transform allows for the direct comparison of gene expression values over different samples and diseases.
In addition to the above Z-score transform, we performed linear regression method on the time series data to obtain a joint t-test statistic between two conditions. Data were transformed using log 2 and the linear regression model for calculating the expression level of each gene was as follows:
where Y i is the gene expression value and X i is a disease state (disease or control). The model parameters β 0 and β 1 were computed using least squares. To identify differentially expressed genes for both disease and control states we applied unpaired t-test, and significant genes were selected by setting thresholds for p-value to at most 0.05 and absolute log Fold Change (log 2 F C) value to at least 1.0. The microarray gene expression datasets were collected from NCBI-GEO dataset [36] . All the datasets were analyzed and compared with the normal subject using NCBIs GEO2R online tool to identify corresponding differentially expressed genes.
The web-based visualization software STRING [37] was used for the construction and analysis of the Protein-Protein Interaction (PPI) network which was further analyzed by Cytoscape (v3.5.1) [38] . An undirected graph representation was used for the PPI network, where the proteins were represented by the nodes and the edges symbolized the interactions between the proteins. We performed a topological analysis using Cyto-Hubba plugin [39] to identify highly connected proteins (i.e., hub proteins) in the network and the degree metrics were employed [40] . For further introspection into the metabolic pathways of the PD, we incorporated the pathway and gene ontology analysis on all the differentially expressed genes that were common among the PD and other risk factors and diseases using the web-based gene set enrichment analysis tool EnrichR [41] . In this analysis, the Gene Ontology (GO) Biological Process (BP) and KEGG pathway databases were selected as annotation sources. For statistical significance, the highest adjusted p-value was considered 0.05 to obtain enrichment results. Obtained GO and pathway were further analyzed by Cytoscape.
III. RESULTS
A. Gene Expression Analysis
To identify the dysregulated genes due to the PD, the gene expression patterns from substantia nigra tissues of 16 PD patients were analyzed and compared with 9 normal subjects (https://www.ncbi.nlm.nih.gov/geo/geo2r/?acc=GSE7621) [28] . A total of 1343 genes with p-value less than 0.05 and log 2 F C value greater than 1.0 were found to be differentially expressed compared to healthy subjects where 544 genes were expressively up-regulated and 779 genes were down-regulated.
In order to investigate the association of the PD with 8 risk factors and type II diabetes, we analyzed messenger RNA (mRNA) microarray data separately for all risk factors and diseases. In this analysis, several steps of statistical method have been followed, and the most significant up-and downregulated genes for each risk factor and disease were selected. We identified a number of differentially expressed genes (1438 in T2D, 958 in ageing, 800 in SL, 739 in HFD, 57 in HC, 824 in HBF, 482 in RMD, 1405 in AC, and 400 in SM) in our analysis.
The common over and under expressed genes among the PD, risk factors and diseases are also detected through a crosscomparative analysis. The findings demonstrated that the PD shares total 51, 45, 26, 43, 4, 42, 20, 69 and 17 prominent genes with T2D, AG, SL, HFD, HC, HBF, RMD, AC, and SM respectively. Two diseasome association networks centered on the PD were built using Cytoscape (v3.5.1) to identify statistically significant associations among these risk factors and diseases [38] . The network shown in Fig. 1 interprets the association among up-regulated and down-regulated genes.
In our study, we found that 2 significant genes AK7 and YME1L1 are commonly up-regulated among the PD, T2D and HFD; 2 up-regulated genes GPR26 and PLK4 are common among the PD, T2D, and RMD; 2 significant genes, MYOZ2 and OFCC1 are commonly up-regulated among the PD, T2D and AC. On the other hand, 3-down regulated genes IGK, IGKC and IGLC1 are common among the PD, T2D, AG and AC; 2 down-regulated genes EPHA7 and HMGA2 are common in the PD, AG, HBF and HFD; 3 down-regulated genes APCDD1L-AS1, MUC4 and IGLC1 are common among the PD, AC and HBF; 3 down-regulated genes DCAF13, FKBP4 and PTPRC are common among the PD, T2D, and HFD; 4 down-regulated genes PCK1, KRTAP19-1, FYB and IGLC1 are common among the PD, AG and AC; 3 down-regulated genes CKAP2, EPHA7 and HMGA2 are common among the PD, AG and SL; 4 down-regulated genes SGCZ, IKZF1, MYCN and IGLC1 are common among PD, T2D and HBF; 3 down-regulated genes SOX4, TLR3 and HIST1H4A are common among the PD, HFD and SL; 2 down-regulated genes JCHAIN and IGKC are common among the PD, AG and SM; 2 down-regulated genes ARHGAP29 and BPI are common among the PD, T2D and RMD; 2 down-regulated genes TFE3 and KNG1 are common among the PD, AC and SL; 2 downregulated genes RHD and IGLC1 are common among the PD, AC and SM; 2 down-regulated genes PTPN1 and HIST1H4A are common among PD, HBF and HFD; 2 down-regulated genes KNG1 and MTHFR are common among the PD, RMD and SL.
B. Protein-Protein Interaction Network Analysis
The PPI network was constructed using all the distinct 260 differentially expressed genes that were common among the PD, other risk factors and T2D (Fig. 2) . Each node in the network represents a protein and an edge indicates the interaction between two proteins. The network is also grouped into 9 clusters representing risk factors and diseases to depict the protein belongings. Notably, each of HIST1H4A and KNG1 proteins belong to the maximum three clusters indicating that they are the common among the PD and other 3 risk factors and T2D, and they interact with other proteins from different clusters. However, each of the proteins MTHFR, GPR26, FKBP4, PTPRC, YME1L1, FYB, IKZF1, PCK1, MYCN, OFCC1, PTPN1 and TLR3 belong to two clusters and interact with other proteins in the network. For topological analysis, a simplified PPI network was constructed using Cyto-Hubba plugin [39] to show 10 most significant hub proteins (Figure-3) , which are ESR1, PTPRC, CD80, KNG1, SAA1, GPR68, PRKCA, RET, TLR3 and IL7R. These hub proteins could be the targeted proteins for the drug development.
C. Pathway and Functional Correlation Analysis
In order to identify the molecular pathways associated with the PD and we have performed pathway analysis on all the differentially expressed genes that were common among the PD, other risk factors and diseases using the KEGG pathway database (http://www.genome.jp/kegg/pathway.html) and the web-based gene set enrichment analysis tool EnrichR [41] . Total 50 pathways were found to be overrepresented among several groups. Notably, two significant pathways that are related to the nervous system have been found which are Glutamatergic synapse (hsa04724) and Serotonergic synapse (hsa04726). These pathways along with some other common pathways are shown in Table I .
Besides, we dug up the overrepresented ontological groups by performing gene biological process ontology enrichment analysis using EnrichR on the commonly dysregulated genes among the PD, other risk factors and diseases. Total 1202 significant gene ontology groups including peripheral nervous system neuron development (GO:0048935), neurotransmitter transport (GO:0006836), neuromuscular synaptic transmission (GO:0007274), peripheral nervous system development (GO:0007422), negative regulation of neurological system process (GO:0031645), regulation of neurotransmitter secretion (GO:0046928), regulation of neuronal synaptic plasticity (GO:0048168), autonomic nervous system development (GO:0048483), sympathetic nervous system development (GO:0048485), neuromuscular process controlling balance (GO:0050885), neuron apoptotic process (GO:0051402), regulation of neurotransmitter transport (GO:0051588) and neuroepithelial cell differentiation (GO:0060563), were observed. Table II summarizes some common genes ontology groups.
IV. DISCUSSION
In this study, we investigated the molecular mechanism of the PD and its genetic association with other risk factors and diseases. For this purpose, we conducted analysis of dysregulation in gene expression of the PD patients, molecular key pathways, ontologies and PPIs. These analyses through networkbased approach can unfold novel relationships between the PD and other susceptibility/risk factor. Findings could be very potential and have not been possessed by any previous individual studies. Our outcomes identified several significant genes that yield an opportunity to identify therapeutic targets for the PD. Besides this, our analysis also identified and characterized various biological functions related with these genes.
Our gene expression analysis showed that the PD is strongly associated with alcohol consumption (69), type II diabetes (51 genes), ageing (45 genes), HFD (43 genes) and HBF (42) as they share the maximum number of genes. We constructed and analyzed the PPI network to have a better understanding of the central mechanism behind the PD. For this reason, to construct a PPI network around the differentially expressed genes for our study, we have combined the results of statistical analyses with the protein interactome network. For finding central proteins (i.e., hubs), topological analysis strategies were employed. These identified Hubs proteins might be considered as candidate biomarkers or potential drug targets. From the PPI network analysis, it is observed that 10 hub genes (ESR1, PTPRC, CD80, KNG1, SAA1, GPR68, PRKCA, RET, TLR3 and IL7R) are involved in the PD.
Furthermore, disease related genes play a vital role in the human interactomes via the pathways. In this study, we identified two significant pathways that are associated with the nervous system which are Glutamatergic synapse and Serotonergic synapse. Our study also identified several gene ontologies groups including peripheral nervous system neuron development, neurotransmitter transport, neuromuscular synaptic transmission, peripheral nervous system development, negative regulation of neurological system process, regulation of neurotransmitter secretion, regulation of neuronal synaptic plasticity, autonomic nervous system development, sympathetic nervous system development, neuromuscular process controlling balance, neuron apoptotic process, regulation of neurotransmitter transport and neuroepithelial cell differentia- tion, which are closely related to the nervous system. We have also analyzed the differentially expressed genes of each risk factor and disease with Online Mendelian Inheritance in Man (OMIM) and dbGAP databases to validate our identified result using the valid gold benchmark druggene associations. Table III summarizes the results. The results corroborate that, the differentially expressed genes of 8 risk factors and type II diabetes cause the PD. As a whole, our findings compensate a major gap of about the PD biology. It will also open up an entry point to establish a mechanistic link among the PD, various risk factors and diseases.
V. CONCLUSION
In this study, genomic data is considered to identify the genetic association of various diseasome relationships with the PD. Our findings elicit that the network methods can illustrate disease progression that yields a potential advancement towards better insight of the origin and evolution of the PD. Detecting the complex relationship of various risk factors with the disease may expose new and useful information important for having a better understanding of overall mechanism as well as planning remedy strategy of the PD. Making genomic based recommendations for accurate disease diagnosis and effective treatment can be boosted by the approaches demonstrated in this study. This enhancement may eventually lead genomic information-based personalized medicine for the more precise insight into disease mechanism, and thus an opportunity to determine accurate diagnosis, treatment and remedy from the PD disease. UNC13C, RBFOX3, BANK1, STAP1, PLAG1  1.68E-01  FAM47E, SNX10, KBTBD11, SNCA, HMGA2  AC  SEMA5A, NEGR1, RAB25, SH3GL2, ADCY2  3.80E-02  BRINP1, PLCB4, SEMA6D, MGAT5, ADCY1  STAP1, CTNNA3, MACROD2, MAPT, IGF1R  FGF12, DLG2, NR4A2, GNAQ, GNAS, ARNT  T2D GABBR2, USP36, AKAP13, SEMA6D 5.49E-01 CYB5RL, DSG3, RREB1, SGCZ, CYP17A1 HNF4A, HMGA2, BUB1, IGF1R HBF PTGIR, THRA, HMGA2, ADCY2, DRD1 2.03E-01 BUB1, FRMPD4, ZNF646, CTNNA3 MACROD2, TNPO2, SGCZ HC IQGAP1 2.32E-01 HFD AKAP13, IL1RL2, ITGA8, RREB1, TNPO2 3.47E-01 GABRG3, CREBBP, HNF4A, HMGA2 RMD C9, ULK2, ZNF385B, GABRG3, SNCA 2.03E-01 HMGA2, ADCY2 SL GAK, NELL1, BRINP1, COL4A1, VWA5A, 2.44E-01 PLEKHM1, PHACTR2, TFAP2A, HSP90AA1, CREB1, THRA, TSHR SM NR4A2, OPRD1, SMAD1, BUB1, PAK1 1.15E-01 CREM, TNPO2
